Private EquityScreenerRefer

MARKET INSIGHTS

  • EventsNEWPrivate market milestones
  • NewsPrecize daily pulse
  • BlogsIn-depth articles and opinions

GUIDES

Explore Now
  • Unlisted SharesStep-by-step · KYC
  • BuyingStep-by-step · KYC
  • SellingExit in 24 - 48 hours
  • Pre-IPOReturns · risks · case studies
  • Tax GuideBudget 2026 changes
  1. Home
  2. Unlisted share news
  3. S3V Vascular Technologies – Indigenous Stroke Care Device Manufacturing

S3V Vascular Technologies – Indigenous Stroke Care Device Manufacturing

1 Jun 2025

Add as preferred source
Key Takeaways

Key Takeaway:

  • S3V's govt-backed initiative to indigenize stroke-care devices addresses a critical import-substitution gap in India's high-end medical device sector, though scaling production, regulatory clearances, and clinical adoption remain key execution risks in a historically multinational-dominated category.


Key Takeaway:

  • S3V's govt-backed initiative to indigenize stroke-care devices addresses a critical import-substitution gap in India's high-end medical device sector, though scaling production, regulatory clearances, and clinical adoption remain key execution risks in a historically multinational-dominated category.


S3V Vascular Technologies

S3V Vascular Technologies

0.00%

Expert Analysis

Expert Analysis:

  • S3V Vascular Technologies, backed by the Technology Development Board, will establish India's first integrated facility for indigenous mechanical thrombectomy devices near Sriperumbudur, Tamil Nadu, producing microcatheters, guidewires, aspiration catheters, and stent retrievers to address India's USD 2 billion neuro-intervention market.​

  • The venture has attracted institutional and investor backing from L&T Chairman Emeritus A.M. Naik, Madhusudan Kela (MK Ventures), and Utpal Sheth (Rare Enterprises), signaling confidence in the medical device import-substitution opportunity and domestic healthcare manufacturing scaling.​

  • S3V's strategy includes proprietary innovations (clot retriever head, braid-over-coil aspiration catheter), CE/USFDA certifications for exports, and partnerships with Ayushman Bharat and hospitals to expand affordable access in Tier-II and rural regions via simulator-based training and public health integration.​

Publisher:Money Control